Invesco Ltd. - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$20,567,315
-80.4%
540,676
-53.1%
0.01%
-78.6%
Q2 2023$104,983,277
+52.9%
1,152,396
+10.7%
0.03%
+47.4%
Q1 2023$68,663,108
+165.2%
1,040,981
+107.9%
0.02%
+137.5%
Q4 2022$25,895,695
-37.1%
500,787
-17.0%
0.01%
-38.5%
Q3 2022$41,202,000
+424.8%
603,253
+247.4%
0.01%
+550.0%
Q2 2022$7,851,000
+16.0%
173,628
+30.4%
0.00%0.0%
Q1 2022$6,768,000
+194.9%
133,183
+174.3%
0.00%
+100.0%
Q4 2021$2,295,000
+27.2%
48,549
-11.3%
0.00%
Q3 2021$1,804,000
-95.2%
54,738
-90.8%
0.00%
-100.0%
Q2 2021$37,725,000
+62.8%
596,916
+10.5%
0.01%
+50.0%
Q1 2021$23,176,000
-27.8%
540,107
-3.7%
0.01%
-33.3%
Q4 2020$32,094,000
+46.4%
561,092
-22.8%
0.01%
+28.6%
Q3 2020$21,927,000
+17.4%
726,777
+27.0%
0.01%0.0%
Q2 2020$18,685,000
+95.0%
572,113
+60.0%
0.01%
+75.0%
Q1 2020$9,582,000
+827.6%
357,676
+777.1%
0.00%
Q2 2019$1,033,00040,7790.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,503,059$170,959,00029.50%
ACUTA CAPITAL PARTNERS, LLC 554,000$37,838,00016.29%
Avoro Capital Advisors LLC 10,125,000$691,538,00012.78%
Sio Capital Management, LLC 507,700$34,676,00011.02%
Logos Global Management LP 1,300,000$88,790,00010.92%
EcoR1 Capital, LLC 5,183,431$354,028,00010.45%
Cormorant Asset Management, LP 1,478,000$100,947,0007.06%
Finepoint Capital LP 266,090$18,174,0005.98%
Ghost Tree Capital, LLC 275,000$18,783,0005.27%
Boxer Capital, LLC 1,303,700$89,043,0005.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders